Review
Nature Reviews Cancer 7, 531-543 (July 2007) | doi:10.1038/nrc2170
Gene methylation and early detection of genitourinary cancer: the road ahead
Paul Cairns1 About the author
Abstract
DNA methylation is a common mechanism of inactivation of tumour-suppressor and other cancer genes in neoplastic cells. The advantages of gene methylation as a target for the detection and diagnosis of cancer in biopsy specimens and non-invasive body fluids such as urine or blood has led to many studies of application in genitourinary cancer. Here, we consider the background, promise and status, challenges and future directions of gene methylation and its clinical utility for the early detection of genitourinary cancer. The challenges of, and strategies for, advancing gene-methylation-based detection are relevant to all types of cancer.
- View At a Glance
Author affiliations
-
Departments of Surgical Oncology and Pathology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
Email: Paul.Cairns@fccc.edu
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3BOncogene Original Article
Quantitative methylation analyses of resection margins predict local recurrences and disease-specific deaths in patients with head and neck squamous cell carcinomasBritish Journal of Cancer Original Article
Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controlsOncogene Scientific Correspondence
Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinomaLaboratory Investigation Research Article
See all 39 matches for Research